Advanced search
Publication Cover
RNA Biology Volume 19, 2022 - Issue 1
Submit an article Journal homepage
4,789
Views
27
CrossRef citations to date
0
Altmetric
Research Paper

Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells

Nadav Wallisa Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelView further author information
,
Froma Obermana Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelView further author information
,
Khriesto Shurrushb The Wohl Drug Discovery Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Nicolas Germainb The Wohl Drug Discovery Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Gila Greenwalda Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelView further author information
,
Tehila Gershona Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelView further author information
,
Talia Pearla Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelView further author information
,
Giancarlo Abisc Division of Biosciences, Institute of Structural and Molecular Biology, University College London, London, UKView further author information
,
Vikash Singhd Department of Pediatrics, Division of Pediatric Hematology/Oncology, Pennsylvania State University, College of Medicine, Hershey, PA, USAView further author information
,
Amandeep Singhe Department of Pharmacology, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USAView further author information
,
Arun K. Sharmae Department of Pharmacology, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USAView further author information
,
Haim M. Barrb The Wohl Drug Discovery Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Andres Ramosc Division of Biosciences, Institute of Structural and Molecular Biology, University College London, London, UKORCID Iconhttps://orcid.org/0000-0002-9295-8042View further author information
ORCID Icon,
Vladimir S. Spiegelmand Department of Pediatrics, Division of Pediatric Hematology/Oncology, Pennsylvania State University, College of Medicine, Hershey, PA, USAView further author information
&
Joel K. Yisraelia Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6538-6686View further author information
ORCID Icon show all
Pages 26-43 | Received 05 Aug 2021, Accepted 22 Nov 2021, Published online: 11 Dec 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.